ALKemist Bio
PrivateLast Round
Seed
Dec 21, 2023
Total Funding Raised
$7.56M
Momentum Score
50 /100
Company Overview
ALKemist Bio is a biotechnology company developing T-cell receptor (TCR-T) cell therapies for ALK-positive cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALKemist Bio Comps
Public and private peers based on sector, stage, and business model.
ALKemist Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 21, 2023 |
ALKemist Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Club degli Investitori | Seed |
| Claris Ventures | Seed |
| Simon Fiduciaria | Seed |
| LIFTT EuroInvest | Seed |
| Italian Angels for Growth | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 2217% MoM, reaching 1.5K.
- Jun 1, 2025
Monthly visitors grew 65% MoM, reaching 1.2K.
ALKemist Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ALKemist Bio's valuation, stock price, and market status.
